Nine patients with stage III and stage IV thymoma were treated with ci
splatin, vincristine, lomustine, cyclophosphamide and prednisolone, Tw
o patients (22%) obtained remission, and four patients (44%) showed no
change for 11 to 31 months. It was found that this five-drug regimen
did not improve the results obtained by other chemotherapy modalities
for thymoma.